110 related articles for article (PubMed ID: 30603780)
1. Cabazitaxel inhibits prostate cancer cell growth by inhibition of androgen receptor and heat shock protein expression.
Rottach AM; Ahrend H; Martin B; Walther R; Zimmermann U; Burchardt M; Stope MB
World J Urol; 2019 Oct; 37(10):2137-2145. PubMed ID: 30603780
[TBL] [Abstract][Full Text] [Related]
2. Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancer.
Mout L; van Royen ME; de Ridder C; Stuurman D; van de Geer WS; Marques R; Buck SAJ; French PJ; van de Werken HJG; Mathijssen RHJ; de Wit R; Lolkema MP; van Weerden WM
EBioMedicine; 2021 Nov; 73():103681. PubMed ID: 34749299
[TBL] [Abstract][Full Text] [Related]
3. The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cells.
Abazid A; Martin B; Choinowski A; McNeill RV; Brandenburg LO; Ziegler P; Zimmermann U; Burchardt M; Erb H; Stope MB
J Cell Biochem; 2019 Oct; 120(10):16711-16722. PubMed ID: 31297844
[TBL] [Abstract][Full Text] [Related]
4. A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells.
Naito R; Kano H; Shimada T; Makino T; Kadomoto S; Iwamoto H; Yaegashi H; Izumi K; Kadono Y; Nakata H; Saito Y; Goto M; Nakagawa-Goto K; Mizokami A
Prostate; 2021 Apr; 81(5):295-306. PubMed ID: 33493355
[TBL] [Abstract][Full Text] [Related]
5. The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90β and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth.
Brünnert D; Langer C; Zimmermann L; Bargou RC; Burchardt M; Chatterjee M; Stope MB
J Cell Biochem; 2020 Jan; 121(1):407-417. PubMed ID: 31222811
[TBL] [Abstract][Full Text] [Related]
6. Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens.
Ylitalo EB; Thysell E; Thellenberg-Karlsson C; Lundholm M; Widmark A; Bergh A; Josefsson A; Brattsand M; Wikström P
Prostate; 2020 Feb; 80(2):214-224. PubMed ID: 31799745
[TBL] [Abstract][Full Text] [Related]
7. Testosterone Diminishes Cabazitaxel Efficacy and Intratumoral Accumulation in a Prostate Cancer Xenograft Model.
Mout L; de Wit R; Stuurman D; Verhoef E; Mathijssen R; de Ridder C; Lolkema M; van Weerden W
EBioMedicine; 2018 Jan; 27():182-186. PubMed ID: 29276148
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel.
Shiota M; Nakamura M; Yokomizo A; Tomoda T; Sakamoto N; Seki N; Hasegawa S; Yunoki T; Harano M; Kuroiwa K; Eto M
Anticancer Res; 2020 Jan; 40(1):335-339. PubMed ID: 31892584
[TBL] [Abstract][Full Text] [Related]
9. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells.
Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH
Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633
[TBL] [Abstract][Full Text] [Related]
10. Co-targeting AR and HSP90 suppresses prostate cancer cell growth and prevents resistance mechanisms.
Centenera MM; Carter SL; Gillis JL; Marrocco-Tallarigo DL; Grose RH; Tilley WD; Butler LM
Endocr Relat Cancer; 2015 Oct; 22(5):805-18. PubMed ID: 26187127
[TBL] [Abstract][Full Text] [Related]
11. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth.
Cha TL; Qiu L; Chen CT; Wen Y; Hung MC
Cancer Res; 2005 Mar; 65(6):2287-95. PubMed ID: 15781642
[TBL] [Abstract][Full Text] [Related]
12. Membrane-associated androgen receptor (AR) potentiates its transcriptional activities by activating heat shock protein 27 (HSP27).
Li J; Fu X; Cao S; Li J; Xing S; Li D; Dong Y; Cardin D; Park HW; Mauvais-Jarvis F; Zhang H
J Biol Chem; 2018 Aug; 293(33):12719-12729. PubMed ID: 29934310
[TBL] [Abstract][Full Text] [Related]
13. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
Yan J; Xie B; Capodice JL; Katz AE
Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835
[TBL] [Abstract][Full Text] [Related]
14. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.
Zoubeidi A; Zardan A; Beraldi E; Fazli L; Sowery R; Rennie P; Nelson C; Gleave M
Cancer Res; 2007 Nov; 67(21):10455-65. PubMed ID: 17974989
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway.
Jang YG; Go RE; Hwang KA; Choi KC
J Steroid Biochem Mol Biol; 2019 Sep; 192():105406. PubMed ID: 31185279
[TBL] [Abstract][Full Text] [Related]
16. Artesunate Suppresses the Growth of Prostatic Cancer Cells through Inhibiting Androgen Receptor.
Wang Z; Wang C; Wu Z; Xue J; Shen B; Zuo W; Wang Z; Wang SL
Biol Pharm Bull; 2017; 40(4):479-485. PubMed ID: 28381803
[TBL] [Abstract][Full Text] [Related]
17. GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer.
Tan SS; Ahmad I; Bennett HL; Singh L; Nixon C; Seywright M; Barnetson RJ; Edwards J; Leung HY
J Pathol; 2011 Jan; 223(1):81-7. PubMed ID: 21125667
[TBL] [Abstract][Full Text] [Related]
18. Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells.
Stope MB; Schubert T; Staar D; Rönnau C; Streitbörger A; Kroeger N; Kubisch C; Zimmermann U; Walther R; Burchardt M
World J Urol; 2012 Jun; 30(3):327-31. PubMed ID: 22362414
[TBL] [Abstract][Full Text] [Related]
19. Shortened isoforms of the androgen receptor are regulated by the cytoprotective heat-shock protein HSPB1 and the tumor-suppressive microRNA miR-1 in prostate cancer cells.
Stope MB; Bradl J; Peters S; Streitbörger A; Weiss M; Zimmermann U; Walther R; Lillig CH; Burchardt M
Anticancer Res; 2013 Nov; 33(11):4921-6. PubMed ID: 24222130
[TBL] [Abstract][Full Text] [Related]
20. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.
Martin SK; Kyprianou N
Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]